Clinical, genomic, and transcriptomic differences between myelodysplastic syndrome/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis (MDS/MPN-RS-T) and myelodysplastic syndrome with ring sideroblasts (MDS-RS)

Am J Hematol. 2021 Jul 1;96(7):E246-E249. doi: 10.1002/ajh.26182. Epub 2021 Apr 24.

Authors

Guillermo Montalban-Bravo¹, Rashmi Kanagal-Shamanna², Faezeh Darbaniyan³, Maria Tariq Siddiqui¹, Koji Sasaki¹, Yue Wei¹, Hui Yang¹, Kelly S Chien¹, Kiran Naqvi¹, Elias Jabbour¹, Tapan M Kadia¹, Naval Daver¹, Courtney DiNardo¹, Farhad Ravandi¹, Naveen Pemmaraju¹, Prithviraj Bose¹, Srdan Verstovsek¹, Sherry Pierce¹, Carlos Bueso-Ramos², Keyur Patel², Kim-Anh Do³, Hagop Kantarjian¹, Guillermo Garcia-Manero¹

Affiliations

¹ Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
² Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
³ Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

PMID: 33811786
DOI: 10.1002/ajh.26182

No abstract available

Publication types

Letter
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't

MeSH terms

Aged
Aged, 80 and over
Anemia, Sideroblastic / genetics*
Female
Gene Expression Regulation, Neoplastic
Humans
Male
Middle Aged
Mutation
Myelodysplastic-Myeloproliferative Diseases / genetics*
Thrombocytosis / genetics*
Transcriptome*

Grants and funding